My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 385

    1.

    Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

    Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study.

    Diabetes. 2002 Apr;51(4):1131-7.PMID: 11916936 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.

    Festa A, Hanley AJ, Tracy RP, D'Agostino R Jr, Haffner SM.

    Circulation. 2003 Oct 14;108(15):1822-30. Epub 2003 Sep 29.PMID: 14517163 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.

    Festa A, Williams K, Tracy RP, Wagenknecht LE, Haffner SM.

    Circulation. 2006 Apr 11;113(14):1753-9. Epub 2006 Apr 3.PMID: 16585388 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.

    Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM.

    Kidney Int. 2000 Oct;58(4):1703-10.PMID: 11012904 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.

    Hanley AJ, D'Agostino R Jr, Wagenknecht LE, Saad MF, Savage PJ, Bergman R, Haffner SM; Insluin Resistance Atrherosclerosis Study.

    Diabetes. 2002 Apr;51(4):1263-70.PMID: 11916954 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

    Festa A, D'Agostino R Jr, Mykkänen L, Tracy RP, Zaccaro DJ, Hales CN, Haffner SM.

    Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):562-8.PMID: 10073958 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study.

    Meigs JB, O'donnell CJ, Tofler GH, Benjamin EJ, Fox CS, Lipinska I, Nathan DM, Sullivan LM, D'Agostino RB, Wilson PW.

    Diabetes. 2006 Feb;55(2):530-7.PMID: 16443791 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.

    Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Kempf J, Zinman B, Haffner SM; insulin resistance atherosclerosis study.

    Diabetes. 2004 Oct;53(10):2623-32.PMID: 15448093 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.

    Hanley AJ, Festa A, D'Agostino RB Jr, Wagenknecht LE, Savage PJ, Tracy RP, Saad MF, Haffner SM.

    Diabetes. 2004 Jul;53(7):1773-81.PMID: 15220201 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.

    Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu D, Freed MI, Herman WH, Holman RR, Jones NP, Lachin JM, Viberti GC; ADOPT Study Group.

    Diabetes. 2006 Aug;55(8):2357-64.PMID: 16873701 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.

    Nagi DK, Mohamed Ali V, Jain SK, Walji S, Yudkin JS.

    Diabet Med. 1996 Jan;13(1):59-64.PMID: 8741814 [PubMed - indexed for MEDLINE]Related articles

    12.

    Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.

    Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhäusl W, Pacini G, Kautzky-Willer A.

    Eur J Clin Invest. 2006 May;36(5):345-52.PMID: 16634839 [PubMed - indexed for MEDLINE]Related articles

    13.

    The relation of body fat mass and distribution to markers of chronic inflammation.

    Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM.

    Int J Obes Relat Metab Disord. 2001 Oct;25(10):1407-15.PMID: 11673759 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?

    Haffner SM, D'Agostino R Jr, Festa A, Bergman RN, Mykkänen L, Karter A, Saad MF, Wagenknecht LE.

    Diabetes Care. 2003 Oct;26(10):2796-803.PMID: 14514582 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups.

    Heald AH, Anderson SG, Ivison F, Laing I, Gibson JM, Cruickshank K.

    Atherosclerosis. 2003 Sep;170(1):79-86.PMID: 12957685 [PubMed - indexed for MEDLINE]Related articles

    16.

    Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study.

    Haffner SM, D'Agostino R Jr, Mykkänen L, Tracy R, Howard B, Rewers M, Selby J, Savage PJ, Saad MF.

    Diabetes Care. 1999 Apr;22(4):562-8.PMID: 10189532 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.

    Pellmé F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O, Taskinen MR, Jansson PA.

    Diabetes. 2003 May;52(5):1182-6.PMID: 12716750 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes.

    Temelkova-Kurktschiev T, Siegert G, Bergmann S, Henkel E, Koehler C, Jaross W, Hanefeld M.

    Metabolism. 2002 Jun;51(6):743-9.PMID: 12037728 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

    D'Agostino RB Jr, Hamman RF, Karter AJ, Mykkanen L, Wagenknecht LE, Haffner SM; Insulin Resistance Atherosclerosis Study Investigators.

    Diabetes Care. 2004 Sep;27(9):2234-40.PMID: 15333490 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.

    Nagi DK, Tracy R, Pratley R.

    Metabolism. 1996 Oct;45(10):1243-7.PMID: 8843179 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity